BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 16/10/2014

New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products; Guidance for Industry; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance for industry entitled "New Chemical Entity Exclusivity Determinations for Certain Fixed-Combination Drug Products." This guidance sets forth a change in the Agency's interpretation of the 5-year new chemical entity (NCE) exclusivity statutory and regulatory provisions as they apply to certain fixed- combination drug products (fixed combinations). As described in the guidance, a drug product will be eligible for 5-year NCE exclusivity if it contains a drug substance that meets the definition of "new chemical entity," regardless of whether that drug substance is approved in a single-ingredient drug product or in certain fixed- combinations. This guidance finalizes the draft guidance issued in February 2014.

Source: Federal Register — Food and Drug AdministrationOpen original release →